Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
February 04 2008 - 10:43AM
PR Newswire (US)
LIVINGSTON, N.J., Feb. 4 /PRNewswire-FirstCall/ -- Milestone
Scientific Inc. (OTC:MLSS) (BULLETIN BOARD: MLSS) , the recognized
leader in advanced injection technologies, today announced that
Scott Mahnken has joined the Company's leadership team as new
Director of Marketing. Tasked with developing and managing a wide
range of strategic marketing and communications initiatives to
promote corporate and product brand awareness and drive sales
growth, Mahnken will report directly to Bob Presutti, Vice
President of Sales and Marketing. "Scott is a welcome addition to
our team, bringing significant marketing expertise, important
industry contacts and relationships, and a 20+ year proven history
of success in achieving tangible, impressive results. His
experience within the professional dental industry coupled with his
demonstrated ability to drive sales through innovative, proactive
marketing programs is sure to play a measurable role in aiding
Milestone to advance its strategic growth objectives," noted
Presutti. "We are particularly excited about Scott helping us to
adopt more effective methods of using outbound telemarketing to
promote greater customer support and product education, while also
increasing sales of our disposable handpieces." Immediately prior
to joining Milestone, Mahnken served as Director of Partnership
Relations at ArcMesa Educators, an organization dedicated to
providing accredited continuing education to medical and dental
providers. From 2000 through 2003, he served as Manager of Sales
and Marketing and Product Manager of SS White Burs, Inc., the
nation's oldest dental equipment manufacturer. While serving as
Director of Sales at Lanmark Group, Inc. from 1994 through 2000,
Mahnken managed the medical/dental ad agency's clients' inside and
outside product sales initiatives where he doubled sales the first
year and achieved 20% sales growth every year thereafter. From 1985
through 1994, he served as District Sales Manager for L'Oreal, a
Fortune 500 health and beauty aids company. Mahnken is a graduate
of the University of New Orleans, where he earned a Bachelors of
Art degree in Business. About Milestone Scientific Inc.
Headquartered in Livingston, New Jersey, Milestone Scientific is
engaged in pioneering proprietary, highly innovative technological
solutions for the medical and dental markets. Central to the
Company's IP platform and product development strategy is its
patented CompuFlo(TM) technology for the improved and painless
delivery of local anesthetic. Specifically, CompuFlo is a
computer-controlled, pressure sensitive infusion, perfusion,
suffusion and aspiration technology, which provides real-time
readouts of pressures, fluid densities and flow rates, enabling the
advanced delivery and removal of a wide array of fluids. The Single
Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia
delivery system which uses this technology provides dentists with
audible and visual signals as to in-tissue pressure. Milestone's
existing painless injection systems are currently sold in 25
countries. For more information on these and other innovative
Milestone products, please visit the Company's web site found at
http://www.milesci.com/. Safe Harbor Statement This press release
contains forward-looking statements regarding the timing and
financial impact of the Milestone's ability to implement its
business plan, expected revenues and future success. These
statements involve a number of risks and uncertainties and are
based on assumptions involving judgments with respect to future
economic, competitive and market conditions and future business
decisions, all of which are difficult or impossible to predict
accurately and many of which are beyond Milestone's control. Some
of the important factors that could cause actual results to differ
materially from those indicated by the forward-looking statements
are general economic conditions, failure to achieve expected
revenue growth, changes in our operating expenses, adverse patent
rulings, FDA or legal developments, competitive pressures, changes
in customer and market requirements and standards, and the risk
factors detailed from time to time in Milestone's periodic filings
with the Securities and Exchange Commission, including without
limitation, Milestone's Annual Report on Form 10-KSB for the year
ended December 31, 2006. The forward looking-statements in this
press release are based upon management's reasonable belief as of
the date hereof. Milestone undertakes no obligation to revise or
update publicly any forward-looking statements for any reason. FOR
MORE INFORMATION, PLEASE CONTACT: Elite Financial Communications
Group, LLC Dodi Handy, President and CEO, or Daniel Conway, Chief
Strategist 407-585-1080 or via email at DATASOURCE: Milestone
Scientific Inc. CONTACT: Dodi Handy, President and CEO, or Daniel
Conway, Chief Strategist, both of Elite Financial Communications
Group, LLC, +1-407-585-1080, , for Milestone Scientific Inc. Web
site: http://www.milesci.com/
Copyright